| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f634e5c354062f119546f00eb6345f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-60 |
| filingDate |
1988-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1990-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ea81f4b825a64e0cea06f6ebc4e1bfa |
| publicationDate |
1990-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4920126-A |
| titleOfInvention |
Barbituric acid derivative and treatment of leukemia and tumors therewith |
| abstract |
N-(2-Fluorophenyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxo-5-pyrimidinecarboxamide, useful for regressing or inhibiting the growth of leukemia and tumors in mammals. The compound has the formula: ##STR1## wherein R 1 and R 2 are selected from hydrogen or a cyclic or acyclic group which forms pyrimidine nucleosides or pseudo nucleosides, and the pharmacologically acceptable acid addition salts thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9199946-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5695921-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015065505-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0075118-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003100549-A1 |
| priorityDate |
1988-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |